Abstract:Food allergy is rising at an alarming rate and is a major public health concern. Globally, food allergy affects over 500 million people, often starting in early childhood and increasingly reported in adults. Commercially, only one approved oral immunotherapy-based treatment is currently available and other allergen-based immunotherapeutic are being investigated in clinical studies. As an alternative approach, a substantial amount of research has been conducted on natural compounds and probiotics, focusing on the immune modes of action, and therapeutic uses of such sources to tackle various immune-related diseases. Food allergy is primarily mediated by IgE antibodies and the suppression of allergic symptoms seems to be mostly modulated through a reduction of allergen-specific IgE antibodies, upregulation of blocking IgG, and downregulation of effector cell activation (e.g., mast cells) or expression of T-helper 2 (Th-2) cytokines. A wide variety of investigations conducted in small animal models or cell-based systems have reported on the efficacy of natural bioactive compounds and probiotics as potential anti-allergic therapeutics. However, very few lead compounds, unlike anti-cancer and anti-microbial applications, have been selected for clinical trials in the treatment of food allergies. Natural products or probiotic-based approaches appear to reduce the symptoms and/or target specific pathways independent of the implicated food allergen. This broad range therapeutic approach essentially provides a major advantage as several different types of food allergens can be targeted with one approach and potentially associated with a lower cost of development. This review provides a brief overview of the immune mechanisms underlying food allergy and allergen-specific immunotherapy, followed by a comprehensive collection of current studies conducted to investigate the therapeutic applications of natural compounds and probiotics, including discussions of their mode of action and immunological aspects of their disease-modifying capabilities.

Role of biologics in severe food allergy

The Role of Biologics in the Treatment of Food Allergy

New biologics for food allergy

Biologic therapy for food allergy

Role of allergen immunotherapy and biologics in allergic diseases

Biologics in Food Allergies: Emerging Therapies

Community and Academic Allergists' Perspectives on Integrating Biologics into Food Allergy Care: A Qualitative Study

Current Use of Probiotics and Prebiotics in Allergy

Biologics in asthma: difficulties and drawbacks

A Comprehensive Review on Natural Bioactive Compounds and Probiotics as Potential Therapeutics in Food Allergy Treatment

A Comprehensive Review of Biologics in Phase III and IV Clinical Trials for Atopic Dermatitis

Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment

Asthma and the Biologics Revolution, Part 2: Failures and the Future Potential

Biotics in atopic diseases: state of the art and future perspectives

The Current State of Biologic Therapies for Treatment of Refractory Asthma

Biomarkers in Food Allergy

Biologic drugs, a new therapeutic paradigm in moderate-severe atopic dermatitis

Utilizing Biologics in Drug Desensitization

Asthma and the Biologics Revolution, Part 1: Here and Now

Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review

[Application of biologicals in patients with food allergies]